PRKAA1 and metabolic dysfunction-associated steatotic liver disease: Our recently study reported that the phosphorylated AMP-activated protein kinase (AMPK) protein level was obviously decreased in the liver of mouse with NAFLD than that of normal liver tissue (Li et al., 2021).